Since the drug and its metabolites are excreted by the kidneys, reduced clearance in patients with renal dysfunction can lead to accumulation and increased toxicity. Provides consistent plasma concentrations compared to oral routes.
How CYP2C9 Metabolism Affects Ketorolac's Efficacy and Safety
Ketorolac administration is a critical consideration for clinicians managing acute pain, as the chosen route directly impacts the speed of analgesia, bioavailability, and overall safety profile. The liver enzyme CYP2C9 plays a vital role in this conversion, which influences the drug’s onset and duration of action.
The total daily dose is strictly capped at 120 mg for adults, with treatment durations limited to a maximum of five days. Impact of Renal and Hepatic Function Both renal and hepatic impairment necessitate significant adjustments to ketorolac dosing.
How CYP2C9 Metabolism Affects Ketorolac's Efficacy and Safety
Oral and Nasal Routes: Convenience and Limitations Oral ketorolac is generally reserved for the later stages of pain management, specifically for transition from injectable therapy. This method is favored for its reliable absorption and relatively rapid onset of action, typically providing analgesic effects within 30 to 60 minutes.
More About Ketorolac route of administration
Looking at Ketorolac route of administration from another angle can help expand the discussion and give readers a second clear paragraph under the same section.
More perspective on Ketorolac route of administration can make the topic easier to follow by connecting earlier points with a few simple takeaways.
